<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2016.01992</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>CpG Oligodeoxynucleotides Induce Differential Cytokine and Chemokine Gene Expression Profiles in Dapulian and Landrace Pigs</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Hu</surname> <given-names>Jiaqing</given-names></name><uri xlink:href="http://loop.frontiersin.org/people/234843/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Yang</surname> <given-names>Dandan</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Hui</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Chuanhao</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zeng</surname> <given-names>Yongqing</given-names></name>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Chen</surname> <given-names>Wei</given-names></name>
<xref ref-type="author-notes" rid="fn002"><sup>&#x0002A;</sup></xref>
</contrib>
</contrib-group>
<aff><institution>Department of Animal Genetics and Breeding, College of Animal Science and Technology, Shandong Agricultural University</institution> <country>Tai&#x00027;an, China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Jos&#x000E9; Roberto Mineo, Federal University of Uberlandia, Brazil</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Manuel Vilanova, University of Porto, Portugal; Roland Lang, University Hospital Erlangen, Germany</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Yongqing Zeng <email>yqzeng&#x00040;sdau.edu.cn</email></p></fn>
<fn fn-type="corresp" id="fn002"><p>Wei Chen <email>wchen&#x00040;sdau.edu.cn</email></p></fn>
<fn fn-type="other" id="fn003"><p>This article was submitted to Microbial Immunology, a section of the journal Frontiers in Microbiology</p></fn></author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>7</volume>
<elocation-id>1992</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>09</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>11</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2016 Hu, Yang, Wang, Li, Zeng and Chen.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Hu, Yang, Wang, Li, Zeng and Chen</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><p>Oligodeoxynucleotides containing unmethylated CpG motifs (CpG ODN) mimic the immunostimulatory activity of microbial DNA by interacting with Toll-like receptor 9 (TLR9) to activate both the innate and adaptive immune responses in different species. However, few studies have been published to compare the effects of CpG ODN on different pig breeds. Therefore, in this study, whole blood gene expression profiles of DPL and Landrace pigs treated with CpG ODN were studied using RNA-seq technology. Five Hundred differentially expressed genes (DEGs) were identified between the two breeds. DPL pigs had significantly higher number of immune-relevant DEGs than the Landrace pigs after CpG ODN treatment. Pathway analysis showed that cytokine-cytokine receptor interaction and chemokine signaling pathway were the major enriched pathways of the immune-relevant DEGs. Further <italic>in vitro</italic> experiments showed that PBMCs of the DPL pigs had significantly higher levels of TLR9 mRNA than those of the Landrace pigs, both before and after CpG ODN stimulation. Cytokine and chemokine induction in the PBMCs of both breeds were also measured after CpG ODN stimulation. Our data showed that mRNA levels of cytokines (IFN&#x003B1;, IL8, IL12 p40) and chemokines (CXCL9, CXCL13) were significantly higher in the PBMCs of the DPL pigs than those of the Landrace pigs. Taken together, our data provide new information regarding the pig breed difference in response to CpG ODN stimulation and that higher levels of TLR9 mRNA in DPL pigs may be a major contributor for disease resistance.</p></abstract>
<kwd-group>
<kwd>pig</kwd>
<kwd>CpG ODN</kwd>
<kwd>cytokines</kwd>
<kwd>chemokines</kwd>
<kwd>transcriptome</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="6"/>
<equation-count count="0"/>
<ref-count count="60"/>
<page-count count="14"/>
<word-count count="8149"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>In the pig production industry, infectious diseases caused by viral and bacterial pathogens seriously influence animal welfare, product quality and economics around the world (Meng, <xref ref-type="bibr" rid="B35">2012</xref>). Breed is one of the most important factors that directly influence resistance or susceptibility to various infectious diseases (Reiner et al., <xref ref-type="bibr" rid="B42">2002</xref>; Opriessnig et al., <xref ref-type="bibr" rid="B40">2006</xref>; Lunney and Chen, <xref ref-type="bibr" rid="B31">2010</xref>). Chinese indigenous pig breeds are generally better at disease resistance than foreign lean-type pig breeds (Yang, <xref ref-type="bibr" rid="B57">2013</xref>). Dapulian (DPL) pigs are an indigenous breed of China, which mainly distribute in Shandong Province, China. Compared to modern commercial pig breeds, DPL pigs exhibit stronger resistance to diseases such as porcine reproductive and respiratory syndrome (PRRS) (Jiang et al., <xref ref-type="bibr" rid="B23">2013</xref>; Xing et al., <xref ref-type="bibr" rid="B56">2014</xref>). Since DPL and Landrace pigs were evolved under different environment and pathogen pressure, they may harbor variants of immune response genes which will help to explain their differences in disease resistance. Therefore, exploring the differential expression of immune response genes in DPL and Landrace pigs will help to understand their disease resistance difference on the molecular level.</p>
<p>Toll-like receptors (TLRs) are a family of pattern recognition receptors (PRR), which recognize invading pathogens by an array of conserved molecular structure known as pathogen-associated molecular patterns (PAMPs), playing critical roles in innate antimicrobial immune responses (Kumar et al., <xref ref-type="bibr" rid="B26">2009</xref>; Takeuchi and Akira, <xref ref-type="bibr" rid="B46">2010</xref>). TLR1, TLR2, TLR4, TLR5, and TLR6 are mainly present on the cell surface and recognize PAMPs derived from bacteria, fungi and protozoa; while TLR3, TLR7, and TLR9 are mainly present on the endosome and recognize PAMPs derived from various viruses and bacteria (Kumar et al., <xref ref-type="bibr" rid="B26">2009</xref>; Takeuchi and Akira, <xref ref-type="bibr" rid="B46">2010</xref>). Moreover, TLR agonists are known to induce intracellular signal transduction cascades and have been identified as therapeutic reagents for a number of diseases (McInturff et al., <xref ref-type="bibr" rid="B34">2005</xref>; Uenishi and Shinkai, <xref ref-type="bibr" rid="B50">2009</xref>). Among the TLRs, TLR9 has been shown to play important roles in host immune responses against a broad range of pathogens (Manuja et al., <xref ref-type="bibr" rid="B32">2013</xref>). TLR polymorphism has been shown to be associated with disease resistance in human (Bhanothu et al., <xref ref-type="bibr" rid="B6">2015</xref>), sheep (Swiderek et al., <xref ref-type="bibr" rid="B44">2006</xref>), and chickens (Liu Y. et al., <xref ref-type="bibr" rid="B29">2011</xref>). Recently it has been suggested that the higher mRNA levels of TLRs may explain why Tibetan pigs have stronger innate immunity compared to Yorkshire pigs (Cheng et al., <xref ref-type="bibr" rid="B10">2015</xref>). Currently there is a lack of information about TLR signaling in DPL and Landrace pigs. Therefore, we hypothesized that differential TLR signaling in DPL and Landrace pigs may explain the difference in their innate and adaptive immune capacity.</p>
<p>Next-generation sequencing (NGS) technology has provided a very useful platform to easily compare DEGs and assess mRNA transcription patterns for all the genes in various species (Wilhelm and Landry, <xref ref-type="bibr" rid="B54">2009</xref>). RNA-seq using NGS technology has become widely used for high-throughput researches of gene expression. Such technology has been successfully used to identify genes associated with economically important quantitative traits, such as body growth, immune, disease resistance, and meat quality (Mu et al., <xref ref-type="bibr" rid="B36">2014</xref>; Sodhi et al., <xref ref-type="bibr" rid="B43">2014</xref>; Ghosh et al., <xref ref-type="bibr" rid="B17">2015</xref>; Xiao et al., <xref ref-type="bibr" rid="B55">2015</xref>). In this study, we compared the gene expression difference in the whole blood samples of DPL and Landrace pigs 6 h after stimulation with class C CpG ODN 2429 (a TLR9 agonist) <italic>in vivo</italic> using RNA-seq technology. Based on the RNA-seq results, we further studied the mRNA expression of TLR9 and cytokine/chemokine in the peripheral blood mononuclear cells (PBMCs) of DPL and Landrace pigs after C CpG ODN 2429 stimulation <italic>in vitro</italic>. 500 DEGs were identified in the whole blood samples between the two pig breeds after CpG ODN stimulation and these DEGs&#x00027; enriched pathways were also explored. Our data also suggest that higher level of TLR9 mRNA in the DPL pigs may contribute to stronger inflammatory reactions through higher cytokine/chemokine expression compared to Landrace pigs.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and methods</title>
<sec>
<title>Animals and ethics statement</title>
<p>Twelve female DPL and twelve female Landrace pigs (all at day 28 of age) were purchased from Jiaxiang DPL Farm, Jining City, China. These pigs were housed in adjacent pens (6 pigs per pen separated by breed) under the same standard conditions to reduce environmental effects on gene expression. The pigs had access to the same food three times a day and water <italic>ad libitum</italic>. All pigs were seronegative for antibodies to PRRS virus, porcine circovirus type 2 (PCV2), pesudorabies virus (PrV), classical swine fever virus and parvovirus as detected by commercial ELISA assays. All animal experiments in this study were conducted in accordance with the Institutional Animal Care and Use Committee of Shandong Agricultural University and the &#x0201C;Guidelines for Experimental Animals&#x0201D; of the Ministry of Science and Technology (Beijing, China).</p>
</sec>
<sec>
<title>Gene expression analysis using RNA-seq</title>
<sec>
<title>Animal treatment and blood sample collection</title>
<p>Six DPL and six Landrace pigs were injected with C CpG ODN 2429 TCGTCGTTTTCGGCGGCCGCCG (CpG) (Shenggong Biotech Co, Shanghai, China) at the dose of 500 &#x003BC;g/kg body weight according to the reference (Dar et al., <xref ref-type="bibr" rid="B14">2010</xref>). The injection was performed on day 35 of age. Whole blood samples were collected from the external jugular vein at 6 h after injection. 1 mL whole blood samples were mixed with 3 ml RNALock Reagent (Tiangen Biotech Co, Beijing, China). The mixture was kept at room temperature for 2 h and then stored at &#x02212;80&#x000B0;C until use.</p>
</sec>
<sec>
<title>cDNA library construction and RNA-seq</title>
<p>Among the 6 pigs from each breed treated with CpG ODN, blood samples from 3 DPL and 3 Landrace pigs were used for RNA-seq experiment. The whole blood RNA was extracted using a RNAsimple Total RNA kit (Tiangen Biotech Co, Beijing, China) according to the manufacturer&#x00027;s instructions. RNA concentration and purity were assessed using a NanoDrop 2000 Spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, USA). RNA integrity was assessed using a RNA Nano 6000 Assay Kit on an Agilent Bioanalyzer 2100 system (Agilent Technologies, CA, USA). According to the manufacturer&#x00027;s recommendations, the sequencing libraries were generated using a NEBNext&#x000AE; Ultra RNA Library Prep Kit from Illumina (New England Biolabs, Ipswich, MA, USA) by Biomarker Technologies Corporation (Beijing, China). Briefly, mRNA was isolated from total RNA using magnetic oligo (dT) beads (Invitrogen, Carlsbad, CA, USA) and was further fragmented into about 200 bp. The first and the second strands of cDNA were synthesized using theses fragmented mRNAs. Finally, the suitable cDNA fragments were PCR-amplified to generate a complete cDNA library. The cDNA library was sequenced using an Illumina HiSeq 2500 instrument at the Biomarker Technologies Corporation (Beijing, China).</p>
</sec>
<sec>
<title>Analysis of RNA-seq data</title>
<p>After discarding low quality sequence reads (reads with adaptors, unknown nucleotides larger than 5%, or Q20 &#x0003C;20%) by perl script, all clean reads were aligned to the reference genome of <italic>Sus scrofa</italic> (<italic>Sscrofa</italic> 10.2; <ext-link ext-link-type="uri" xlink:href="ftp://ftp.ensembl.org/pub/release-75/fasta/sus_scrofa/">ftp://ftp.ensembl.org/pub/release-75/fasta/sus_scrofa/</ext-link>) using the TopHat2 software. The gene expression levels were calculated using the FPKM (fragments per kilobase of exon per million fragments mapped) values generated by the Cufflinks software (Trapnell et al., <xref ref-type="bibr" rid="B48">2010</xref>). Genes (FPKM &#x0003E; 0.1) that were detected commonly in all six samples were assigned as co-genes. The DEGs were analyzed using the R package DESeq (Anders and Huber, <xref ref-type="bibr" rid="B2">2010</xref>). The genes with Fold changes (log2Ratio) &#x02265;2 and FDR significance score &#x0003C;0.01 were regarded as DE Gs. The false discovery rate (FDR) was used to evaluate the <italic>p</italic>-value in multiple tests. The <italic>p</italic>-value of the original hypothesis test was further corrected using the accepted Benjamini-Hochberg correction method.</p>
<p>All DEGs were submitted to the databases of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) for enrichment analysis. GO analysis was performed using the Blast2 GO software (Conesa et al., <xref ref-type="bibr" rid="B13">2005</xref>) to annotate the function of these DEGs. Moreover, the KEGG database was used for the DEGs enriched pathway analysis (<ext-link ext-link-type="uri" xlink:href="http://www.genome.ad.jp/kegg/">http://www.genome.ad.jp/kegg/</ext-link>).</p>
</sec>
</sec>
<sec>
<title>TLR9 mRNA expression in the PBMCs of DPL and landrace pigs</title>
<sec>
<title>Isolation of PBMCs and CpG ODN treatment</title>
<p>Whole blood samples from the remaining six DPL and six Landrace pigs also at day 35 after birth were collected via external jugular vein using 10 mL vacutainers coated with EDTA. PBMCs were isolated by FICOLL density gradient centrifugation as described by Fuss et al. (<xref ref-type="bibr" rid="B16">2009</xref>). Isolated PBMCs were re-suspended in RPMI 1640 medium supplemented with 10% feta bovine serum. PBMCs (1 &#x000D7; 10<sup>6</sup> cells/mL) were stimulated with 5 &#x003BC;g/mL TLR9 ligand CpG ODN for 6, 12, and 24 h according to the reference (Auray et al., <xref ref-type="bibr" rid="B4">2013</xref>). Control cells were cultured under the same condition except no TLR ligand treatment.</p>
</sec>
<sec>
<title>Gene expression assay using quantitative real-time PCR (qRT-PCR)</title>
<p>Total RNA of the PBMCs was extracted using Trizol (Takara Biotechnology, Dalian, China) according to the manufacturer&#x00027;s instructions. The quantity and quality of the isolated RNA were determined via UV260/280 using a biophotometer (Eppendorf, Hamburg, Germany). A two-step qRT-PCR Kit (Takara Biotechnology, Dalian, China) was used to generate cDNA according to the manufacturer&#x00027;s instructions. qRT-PCR was performed using a SYBR Premix Ex Taq kit (Takara Biotechnology, Dalian, China) on MX3000p RealTime PCR System (Stratagene, La Jolla, CA, USA). The primers (listed in Table <xref ref-type="table" rid="T1">1</xref>) were either from published literature or designed in house using Premier 5.0 software (Applied Biosystems, Foster City, USA). B2M and PPIA genes were used as housekeeping genes (Wang et al., <xref ref-type="bibr" rid="B53">2015</xref>). The gene expression differences were calculated using the 2<sup>&#x02212;&#x00394;&#x00394;CT</sup> method (Livak and Schmittgen, <xref ref-type="bibr" rid="B30">2001</xref>).</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p><bold>Primer sequences used in this study</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>Primer name</bold></th>
<th valign="top" align="left"><bold>Sequence (5&#x02032;-3&#x02032;)</bold></th>
<th valign="top" align="center"><bold>Production size (bp)<xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref></bold></th>
<th valign="top" align="left"><bold>References<xref ref-type="table-fn" rid="TN2"><sup>b</sup></xref></bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">IFN&#x003B1;-F</td>
<td valign="top" align="left">CTGGCTGTGAGGAAATACTT</td>
<td valign="top" align="center">118</td>
<td valign="top" align="left"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_001166318.1">NM_001166318.1</ext-link></td>
</tr>
<tr>
<td valign="top" align="left">IFN&#x003B1;-R</td>
<td valign="top" align="left">TTGTGGAGGAAGAGAAGACT</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">IFN&#x003B3;-F</td>
<td valign="top" align="left">GGAGCATGGATGTGATGAAG</td>
<td valign="top" align="center">137</td>
<td valign="top" align="left">Du et al., <xref ref-type="bibr" rid="B15">2016</xref></td>
</tr>
<tr>
<td valign="top" align="left">IFN&#x003B3;-R</td>
<td valign="top" align="left">GAGTTCACTGATGGCTTTGC</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">TLR9-F</td>
<td valign="top" align="left">GGCCTTCAGCTTCACCTTGG</td>
<td valign="top" align="center">151</td>
<td valign="top" align="left">Auray et al., <xref ref-type="bibr" rid="B3">2010</xref></td>
</tr>
<tr>
<td valign="top" align="left">TLR9-R</td>
<td valign="top" align="left">GGTCAGCGGCACAAACTGAG</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">CXCL10-F</td>
<td valign="top" align="left">CTGTTCGCTGTACCTGCATC</td>
<td valign="top" align="center">232</td>
<td valign="top" align="left"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_001008691.1">NM_001008691.1</ext-link></td>
</tr>
<tr>
<td valign="top" align="left">CXCL10-R</td>
<td valign="top" align="left">GCTTCTCTCTGTGTTCGAGG</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">CXCL13-F</td>
<td valign="top" align="left">TTCTGGAGACCAATGACACA</td>
<td valign="top" align="center">172</td>
<td valign="top" align="left"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="XM_003129101.2">XM_003129101.2</ext-link></td>
</tr>
<tr>
<td valign="top" align="left">CXCL13-R</td>
<td valign="top" align="left">TGAGGGTTCAAGCAGATAGC</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">CXCL9-F</td>
<td valign="top" align="left">TCAACACCAGCCAAAGGATG</td>
<td valign="top" align="center">180</td>
<td valign="top" align="left"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_001114289.2">NM_001114289.2</ext-link></td>
</tr>
<tr>
<td valign="top" align="left">CXCL9-R</td>
<td valign="top" align="left">TGACCTGTTTCTCCCACTCT</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">CCL19-F</td>
<td valign="top" align="left">TGCCAACGATGCTGAAGACT</td>
<td valign="top" align="center">231</td>
<td valign="top" align="left"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_001170516.1">NM_001170516.1</ext-link></td>
</tr>
<tr>
<td valign="top" align="left">CCL19-R</td>
<td valign="top" align="left">TAGTTGCGGTGGTGCTTGCT</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">MYD88-F</td>
<td valign="top" align="left">GGAACAGACCAACTATCGGC</td>
<td valign="top" align="center">126</td>
<td valign="top" align="left">Hu et al., <xref ref-type="bibr" rid="B22">2016</xref></td>
</tr>
<tr>
<td valign="top" align="left">MYD88-R</td>
<td valign="top" align="left">GAGACAACCACTACCATCCG</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">CCL3L1-F</td>
<td valign="top" align="left">CTTCCTCGCAAATTCGTAGC</td>
<td valign="top" align="center">152</td>
<td valign="top" align="left"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_001009579.1">NM_001009579.1</ext-link></td>
</tr>
<tr>
<td valign="top" align="left">CCL3L1-R</td>
<td valign="top" align="left">GCATTCAGCTCCAGGTCAG</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">IL12 p40-F</td>
<td valign="top" align="left">GGGTGGGAACACAAGAGAT</td>
<td valign="top" align="center">154</td>
<td valign="top" align="left">Hu et al., <xref ref-type="bibr" rid="B22">2016</xref></td>
</tr>
<tr>
<td valign="top" align="left">IL12 p40-R</td>
<td valign="top" align="left">GGCTAAACTTGCCTAGAGGT</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">B2M-F</td>
<td valign="top" align="left">TTCACACCGCTCCAGTAG</td>
<td valign="top" align="center">166</td>
<td valign="top" align="left">Martino et al., <xref ref-type="bibr" rid="B33">2011</xref></td>
</tr>
<tr>
<td valign="top" align="left">B2M-R</td>
<td valign="top" align="left">CCAGATACATAGCAGTTCAGG</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">PPIA-F</td>
<td valign="top" align="left">CACAAACGGTTCCCAGTTT</td>
<td valign="top" align="center">171</td>
<td valign="top" align="left">Cinar et al., <xref ref-type="bibr" rid="B11">2013</xref></td>
</tr>
<tr>
<td valign="top" align="left">PPIA-R</td>
<td valign="top" align="left">TGTCCACAGTCAGCAATGGT</td>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>F, Forward primer. R, Reverse primer</italic>.</p>
<fn id="TN1"><label>a</label><p><italic>Amplicon length in base pairs</italic>.</p></fn>
<fn id="TN2"><label>b</label><p><italic>Genbank accession number of cDNA and corresponding gene, available at <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov</ext-link></italic></p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec>
<title>Statistical analysis</title>
<p>The expression of genes with &#x02265;2-fold change and FDR adjusted <italic>p</italic>-value of &#x0003C;0.01 were considered significantly different in the RNA-seq results. qRT-PCR data were analyzed using one-way or two-way ANOVA with a Bonferroni post hoc test. <italic>P</italic> &#x0003C; 0.05 is considered significant.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Overview of the sequencing data</title>
<p>In this study, we obtained approximately 31.4 gigabases (Gb) reads from the six RNA-seq libraries. After discarding low-quality reads, high percentage of the reads were mapped to the pig reference genome, ranging from 74.03 to 81.39%. Among the mapped reads, 69.74&#x02013;78.96% were mapped uniquely to the pig reference genome. All six samples had nearly 90% reads equal to or exceeding Q30 (Table <xref ref-type="table" rid="T2">2</xref>). Pairwise correlation was used to evaluate the individual variation in the blood samples. Except DPL1, all other five samples had very high Spearman correlations across all genes (ranging from 0.985 to 0.998). DPL1&#x00027;s Spearman correlation was very different from the other DPL sample (Spearman correlation for DPL1 across all genes only ranging from 0.474 to 0.460; Table <xref ref-type="table" rid="T3">3</xref>). Therefore, DPL1 sample was excluded from further analysis The RNA-seq data were deposited into NCBI BioProject database, and its accession number is <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="PRJNA309200">PRJNA309200</ext-link>.</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p><bold>A summary of the sequencing reads alignment to the <italic>Sus scrofa</italic> genome</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>Sample</bold></th>
<th valign="top" align="center"><bold>Landrace 1</bold></th>
<th valign="top" align="center"><bold>Landrace 2</bold></th>
<th valign="top" align="center"><bold>Landrace 3</bold></th>
<th valign="top" align="center"><bold>DPL 1</bold></th>
<th valign="top" align="center"><bold>DPL 2</bold></th>
<th valign="top" align="center"><bold>DPL 3</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Total reads</td>
<td valign="top" align="center">48,632,150</td>
<td valign="top" align="center">39,206,506</td>
<td valign="top" align="center">42,966,768</td>
<td valign="top" align="center">32,416,978</td>
<td valign="top" align="center">44,590,578</td>
<td valign="top" align="center">43,659,992</td>
</tr>
<tr>
<td valign="top" align="left">Total base pairs</td>
<td valign="top" align="center">6,127,650,900</td>
<td valign="top" align="center">4,940,019,756</td>
<td valign="top" align="center">5,413,812,768</td>
<td valign="top" align="center">4,084,539,228</td>
<td valign="top" align="center">5,618,412,828</td>
<td valign="top" align="center">5,501,158,992</td>
</tr>
<tr>
<td valign="top" align="left">Mapped reads</td>
<td valign="top" align="center">39,582,267 81.39%</td>
<td valign="top" align="center">30,911,049 78.84%</td>
<td valign="top" align="center">33,909,206 78.92%</td>
<td valign="top" align="center">23,998,577 74.03%</td>
<td valign="top" align="center">35,345,365 79.27%</td>
<td valign="top" align="center">34,459,642 78.93%</td>
</tr>
<tr>
<td valign="top" align="left">Uniq mapped reads</td>
<td valign="top" align="center">38,400,961 78.96%</td>
<td valign="top" align="center">30,054,581 76.66%</td>
<td valign="top" align="center">32,696,054 76.10%</td>
<td valign="top" align="center">22,607,515 69.74%</td>
<td valign="top" align="center">33,916,617 76.06%</td>
<td valign="top" align="center">33,195,934 76.03%</td>
</tr>
<tr>
<td valign="top" align="left">%&#x02265;Q30</td>
<td valign="top" align="center">90.01</td>
<td valign="top" align="center">89.39</td>
<td valign="top" align="center">89.52</td>
<td valign="top" align="center">90.39</td>
<td valign="top" align="center">89.58</td>
<td valign="top" align="center">89.62</td>
</tr>
<tr>
<td valign="top" align="left">GC content %</td>
<td valign="top" align="center">58.36</td>
<td valign="top" align="center">58.84</td>
<td valign="top" align="center">58.07</td>
<td valign="top" align="center">55.94</td>
<td valign="top" align="center">57.91</td>
<td valign="top" align="center">58.14</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p><bold>Biology repeat correlation statistics</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>Sample 1</bold></th>
<th valign="top" align="center"><bold>Sample 2</bold></th>
<th valign="top" align="center"><bold>r<sup>2</sup></bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">L1</td>
<td valign="top" align="center">L2</td>
<td valign="top" align="center">0.9856</td>
</tr>
<tr>
<td valign="top" align="left">L1</td>
<td valign="top" align="center">L3</td>
<td valign="top" align="center">0.9946</td>
</tr>
<tr>
<td valign="top" align="left">L2</td>
<td valign="top" align="center">L3</td>
<td valign="top" align="center">0.9873</td>
</tr>
<tr>
<td valign="top" align="left">DPL1</td>
<td valign="top" align="center">DPL2</td>
<td valign="top" align="center">0.4738</td>
</tr>
<tr>
<td valign="top" align="left">DPL1</td>
<td valign="top" align="center">DPL3</td>
<td valign="top" align="center">0.4597</td>
</tr>
<tr>
<td valign="top" align="left">DPL2</td>
<td valign="top" align="center">DPL3</td>
<td valign="top" align="center">0.9985</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>Identification and analysis of DEGs</title>
<p>After bioinformatics analysis, 500 genes were found to be differentially expressed in the whole blood samples of DPL and Landrace pigs. 64.2% (321 genes) of the DEGs had higher expression in the Landrace pigs, while 35.8% (179 genes) DEGs had higher expression in the DPL pigs. A heatmap of the DEGs was shown in Figure <xref ref-type="fig" rid="F1">1</xref> and more detailed information of the DEGs was listed in Supplementary Table <xref ref-type="supplementary-material" rid="SM1">1</xref>, including their log fold difference and FDR values.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>Heatmap of the DEGs between the DPL and Landrace pigs</bold>. Columns represent individual samples. Rows indicate genes with significant expression differences between the two breeds. The color represents the gene expression levels in the sample. From 0 to 10, the gene expression levels increase gradually.</p></caption>
<graphic xlink:href="fmicb-07-01992-g0001.tif"/>
</fig>
</sec>
<sec>
<title>GO and KEGG pathway enrichment analysis of DEGs</title>
<p>To define the biological functions of the 500 DEGs, GO and KEGG analysis were performed. Fifty-two significantly enriched GO terms were identified. The main biological functions identified by GO analysis included molecular function, biological process and cellular component (Figure <xref ref-type="fig" rid="F2">2</xref>). The results have shown that the main functional groups of DEGs in cellular component were cell part, cell, organelle, and membrane; in molecular function were binding, catalytic activity; and in biological process were cellular process, single-organism process, biological regulation and metabolic process. Meanwhile, immune-relevant pathways were significantly enriched in the KEGG pathway analysis, including cytokine-cytokine receptor interaction, chemokine signaling pathway, MAPK signaling pathway, TLR signaling pathway, Jak-STAT signaling pathway, natural killer cell mediated cytotoxicity, and NOD-like receptor signaling pathway. The major pathways were listed in Table <xref ref-type="table" rid="T4">4</xref> and Figure <xref ref-type="fig" rid="F3">3</xref>.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>GO analysis of DEGs between the DPL and Landrace pigs</bold>. The DEGs are classified into three categories: cellular component, molecular function, and biological process. The percentage of genes in each category and the number of genes are shown above.</p></caption>
<graphic xlink:href="fmicb-07-01992-g0002.tif"/>
</fig>
<table-wrap position="float" id="T4">
<label>Table 4</label>
<caption><p><bold>The major enriched KEGG pathways analysis from DEGs in DPL and Landrace pigs</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>Pathway</bold></th>
<th valign="top" align="left"><bold>Ko ID</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Genes</bold></th>
</tr>
<tr>
<th/>
<th/>
<th valign="top" align="left"><bold>Down-regulated in Landrace</bold></th>
<th valign="top" align="left"><bold>Up-regulated in Landrace</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Cytokine-cytokine receptor interaction</td>
<td valign="top" align="left">ko04060</td>
<td valign="top" align="left">TNFRSF18; IL12RB2; IL1B; IL1A; IL8; CXCL2; CXCL10; OSM; CCL19; CXCR6; CSF3; CCL4; CCL3L1; CCL2; CXCL9; CCR2; CCR5; CSF1; CXCL13; IL2RB</td>
<td valign="top" align="left">LTBR; CCL23; CCR2; KIT; CSF1R; TNFSF13</td>
</tr>
<tr>
<td valign="top" align="left">Pathways in cancer</td>
<td valign="top" align="left">ko05200</td>
<td valign="top" align="left">FOS; TRAF3; TRAF2; PLCG1; IL8; CASP3; NOS2; PIAP; JUN</td>
<td valign="top" align="left">MAX; BCL-XL; KIT; NCOA4; CSF1R; ITGA2B;</td>
</tr>
<tr>
<td valign="top" align="left">Chemokine signaling pathway</td>
<td valign="top" align="left">ko04062</td>
<td valign="top" align="left">IL8; CXCL2; CXCL10; CCL19; CXCR6; CCL4; CCL3L1; CCL2; CXCL9; CCR2; CCR5; CXCL13</td>
<td valign="top" align="left">FOXO3A; CCL23; CCR2</td>
</tr>
<tr>
<td valign="top" align="left">MAPK signaling pathway</td>
<td valign="top" align="left">ko04010</td>
<td valign="top" align="left">FOS; PLA2G2D; TRAF2; IL1B; IL1A; CASP3; DUSP4; JUN; Pig_newGene_8380</td>
<td valign="top" align="left">MAX; RPS6KA2</td>
</tr>
<tr>
<td valign="top" align="left">Toll-like receptor signaling pathway</td>
<td valign="top" align="left">ko04620</td>
<td valign="top" align="left">FOS; TRAF3; IL1B; IL8; CXCL10; CXCL9; JUN</td>
<td valign="top" align="left">ENSSSCG0000000900; MYD88; IRF5</td>
</tr>
<tr>
<td valign="top" align="left">Jak-STAT signaling pathway</td>
<td valign="top" align="left">ko04630</td>
<td valign="top" align="left">CCND2; IL12RB2; OSM; CSF3; ENSSSCG00000022485; ENSSSCG00000029668</td>
<td valign="top" align="left">BCL-XL</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><bold>KEGG analysis of DEGs between the DPL and Landrace pigs after CpG ODN stimulation</bold>. The number of genes in each category are shown above.</p></caption>
<graphic xlink:href="fmicb-07-01992-g0003.tif"/>
</fig>
</sec>
<sec>
<title>DEGs associated with immunity</title>
<p>Immune relevant DEGs were significantly enriched in cytokine-cytokine receptor interaction and chemokine signaling pathway. It is worth noting that 82.8% of the immune relevant DEGs (24 out of 29) had higher expression in the DPL pigs compared to the Landrace pigs, such as IL1&#x003B1;, IL1&#x003B2;, CXCL8, CXCL10, CCL19, CXCR6 (The DPL/Landrace gene ratios were 3.33-, 1.74-, 5.63-, 2.24-, 5.55- and 3.55-fold respectively) and so on. Only 17.2% of the immune relevant DEGs (5 out of 29) had higher expression in the Landrace pigs compared to the DPL pigs, such as MyD88, CCL23, CCR2 and IRF5(the Landrace/DPL gene ratios were 6.1845-, 1.34-, 1.39-, and 1.20-fold respectively). The detailed information of the major immune relevant enriched genes were shown in Table <xref ref-type="table" rid="T5">5</xref>.</p>
<table-wrap position="float" id="T5">
<label>Table 5</label>
<caption><p><bold>Detailed information of the 29 major immune relevant DEGs in response to CpG ODN stimulation in DPL and Landrace pigs</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>Sus scrofa Ensemble ID</bold></th>
<th valign="top" align="left"><bold>Gene</bold></th>
<th valign="top" align="center"><bold>FDR</bold></th>
<th valign="top" align="center"><bold>Fold change (Landrace/DPL)</bold></th>
<th valign="top" align="left"><bold>Regulation (Landrace/DPL)</bold></th>
<th valign="top" align="left"><bold>Description</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">ENSSSCG00000002525</td>
<td valign="top" align="left">TRAF3</td>
<td valign="top" align="center">0.004304</td>
<td valign="top" align="center">&#x02212;1.26584</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">TNF receptor-associated factor 3-like</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000003330</td>
<td valign="top" align="left">TNFRSF18</td>
<td valign="top" align="center">1.02E-07</td>
<td valign="top" align="center">&#x02212;2.01619</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">Tumor necrosis factor receptor superfamily member 18-like</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000003799</td>
<td valign="top" align="left">IL12RB2</td>
<td valign="top" align="center">0.000604</td>
<td valign="top" align="center">&#x02212;2.13986</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">Interleukin-12 receptor subunit beta-2 precursor</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000005838</td>
<td valign="top" align="left">TRAF2</td>
<td valign="top" align="center">0.001752</td>
<td valign="top" align="center">&#x02212;1.12747</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">TNF receptor-associated factor 2</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000008088</td>
<td valign="top" align="left">IL1B1</td>
<td valign="top" align="center">2.89E-06</td>
<td valign="top" align="center">&#x02212;1.7407</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">Interleukin-1 beta precursor</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000008090</td>
<td valign="top" align="left">IL1A</td>
<td valign="top" align="center">0.003754</td>
<td valign="top" align="center">&#x02212;3.32519</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">Interleukin-1 alpha precursor</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000008953</td>
<td valign="top" align="left">CXCL8</td>
<td valign="top" align="center">5.59E-11</td>
<td valign="top" align="center">&#x02212;5.63162</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">Interleukin-8 precursor</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000008959</td>
<td valign="top" align="left">CXCL2</td>
<td valign="top" align="center">0.007887</td>
<td valign="top" align="center">&#x00023;NAME?</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">C-X-C motif chemokine 2 precursor</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000008977</td>
<td valign="top" align="left">CXCL10</td>
<td valign="top" align="center">2.09E-12</td>
<td valign="top" align="center">&#x02212;2.24248</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">C-X-C motif chemokine 10 precursor</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000009469</td>
<td valign="top" align="left">IRG1</td>
<td valign="top" align="center">8.15E-05</td>
<td valign="top" align="center">&#x02212;2.5073</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">Immune-responsive gene 1 protein homolog</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000010966</td>
<td valign="top" align="left">CCL19</td>
<td valign="top" align="center">1.48E-11</td>
<td valign="top" align="center">&#x02212;5.54945</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">C-C motif chemokine 19 precursor</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000011318</td>
<td valign="top" align="left">CXCR6</td>
<td valign="top" align="center">1.98E-05</td>
<td valign="top" align="center">&#x02212;3.54542</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">C-X-C chemokine receptor type 6</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000014441</td>
<td valign="top" align="left">CSF1R</td>
<td valign="top" align="center">0.007496</td>
<td valign="top" align="center">1.315574</td>
<td valign="top" align="left">Up</td>
<td valign="top" align="left">Macrophage colony-stimulating factor 1 receptor</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000016573</td>
<td valign="top" align="left">IRF5</td>
<td valign="top" align="center">0.001758</td>
<td valign="top" align="center">1.201847</td>
<td valign="top" align="left">Up</td>
<td valign="top" align="left">Interferon regulatory factor 5-like isoform 1</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000017698</td>
<td valign="top" align="left">CCL4</td>
<td valign="top" align="center">1.79E-06</td>
<td valign="top" align="center">&#x02212;2.35038</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">C-C motif chemokine 4 precursor</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000017700</td>
<td valign="top" align="left">CCL3L1</td>
<td valign="top" align="center">1.17E-12</td>
<td valign="top" align="center">&#x02212;2.73058</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">C-C motif chemokine 3-like 1 precursor</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000017702</td>
<td valign="top" align="left">CCL23</td>
<td valign="top" align="center">0.0012</td>
<td valign="top" align="center">1.341277</td>
<td valign="top" align="left">Up</td>
<td valign="top" align="left">C-C motif chemokine 23-like</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000017723</td>
<td valign="top" align="left">CCL2</td>
<td valign="top" align="center">0.00608</td>
<td valign="top" align="center">&#x02212;4.09919</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">C-C motif chemokine 2 precursor</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000021847</td>
<td valign="top" align="left">SAA4</td>
<td valign="top" align="center">3.61E-71</td>
<td valign="top" align="center">&#x02212;6.49546</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">Serum amyloid A-4 protein-like</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000022737</td>
<td valign="top" align="left">Myd88</td>
<td valign="top" align="center">0.006187</td>
<td valign="top" align="center">6.18454</td>
<td valign="top" align="left">Up</td>
<td valign="top" align="left">Myeloid differentiation primary response protein MyD88-like</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000023489</td>
<td valign="top" align="left">CXCL9</td>
<td valign="top" align="center">0.005054</td>
<td valign="top" align="center">&#x00023;NAME?</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">C-X-C motif chemokine 9 precursor</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000024270</td>
<td valign="top" align="left">CCR2</td>
<td valign="top" align="center">0.001995</td>
<td valign="top" align="center">&#x00023;NAME?</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">C-C chemokine receptor type 2</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000024311</td>
<td valign="top" align="left">CCR2</td>
<td valign="top" align="center">0.000314</td>
<td valign="top" align="center">1.396261</td>
<td valign="top" align="left">Up</td>
<td valign="top" align="left">C-C chemokine receptor type 2</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000024344</td>
<td valign="top" align="left">CCR5</td>
<td valign="top" align="center">2.58E-05</td>
<td valign="top" align="center">&#x02212;1.62968</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">C-C chemokine receptor type 5</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000024914</td>
<td valign="top" align="left">CFB</td>
<td valign="top" align="center">1.68E-06</td>
<td valign="top" align="center">&#x02212;4.21557</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">Complement factor B precursor</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000026832</td>
<td valign="top" align="left">CSF1</td>
<td valign="top" align="center">0.000255</td>
<td valign="top" align="center">&#x02212;2.19443</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">Macrophage colony-stimulating factor 1 precursor</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000028731</td>
<td valign="top" align="left">CXCL13</td>
<td valign="top" align="center">5.59E-11</td>
<td valign="top" align="center">&#x02212;6.87266</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">C-X-C motif chemokine 13-like</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000028875</td>
<td valign="top" align="left">HAVCR2</td>
<td valign="top" align="center">1.58E-15</td>
<td valign="top" align="center">&#x02212;3.98527</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">Hepatitis A virus cellular receptor 2-like</td>
</tr>
<tr>
<td valign="top" align="left">ENSSSCG00000029668</td>
<td valign="top" align="left">IL2RB</td>
<td valign="top" align="center">5.34E-08</td>
<td valign="top" align="center">&#x02212;1.75442</td>
<td valign="top" align="left">Down</td>
<td valign="top" align="left">Interleukin-2 receptor subunit beta-like</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>qRT-PCR validation of the gene expression data from RNA-seq</title>
<p>To verify the gene expression data by the RNA-seq, qRT-PCR was performed for six biologically important genesfor immunity, including one gene with lower expression level and five genes with higher expression levels in the Landrace pigs compared to the DPL pigs. qRT-PCR validation was performed using blood samples from all the pigs injected with CpG ODN except DPL1 (i.e., 5 DPL and 6 Landrace pigs injected with CpG ODN). Gene expression fold changes of Landrace/DPL in qRT-PCR analysis and RNA-seq were shown in Figure <xref ref-type="fig" rid="F4">4</xref> and Table <xref ref-type="table" rid="T6">6</xref>. The expression patterns of the six genes were generally consistent with the RNA-seq results, suggesting that the results of the RNA-seq experiments were accurate and reliable.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p><bold>Validation of 6 identified DEGs from RNA-seq results using qRT-PCR</bold>. Positive and negative values are either up or down regulated genes in comparisons (Landrace/DPL). qRT-PCR data were calculated by the 2<sup>&#x02212;&#x00394;&#x00394;CT</sup> method. The direction and magnitude of the fold changes obtained using the qRT-PCR technique were similar to those of the RNA-seq data (<sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.05, <sup>&#x0002A;&#x0002A;</sup><italic>p</italic> &#x0003C; 0.01). <italic>p</italic>: Student&#x00027;s <italic>t</italic>-test <italic>p</italic>-values between DPL and Landrace. <sup>&#x0002A;</sup>Significant (<italic>p</italic> &#x0003C; 0.05) difference, <sup>&#x0002A;&#x0002A;</sup>extremely Significant (<italic>p</italic> &#x0003C; 0.01) difference.</p></caption>
<graphic xlink:href="fmicb-07-01992-g0004.tif"/>
</fig>
<table-wrap position="float" id="T6">
<label>Table 6</label>
<caption><p><bold>The mean &#x000B1; SD of the DPL and Landrace pigs validated by qRT-PCR. <italic>p</italic>: Student&#x00027;s <italic>t</italic>-test <italic>p</italic>-values between DPL and Landrace</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>Gene</bold></th>
<th valign="top" align="center"><bold>Myd88</bold></th>
<th valign="top" align="center"><bold>CXCL8</bold></th>
<th valign="top" align="center"><bold>CXCL10</bold></th>
<th valign="top" align="center"><bold>CCL19</bold></th>
<th valign="top" align="center"><bold>CCL3L1</bold></th>
<th valign="top" align="center"><bold>CXCL13</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">DPL</td>
<td valign="top" align="center">0.93 &#x000B1; 0.07</td>
<td valign="top" align="center">1.32 &#x000B1; 0.36</td>
<td valign="top" align="center">1.19 &#x000B1; 0.33</td>
<td valign="top" align="center">1.13 &#x000B1; 0.34</td>
<td valign="top" align="center">1.14 &#x000B1; 0.23</td>
<td valign="top" align="center">1.23 &#x000B1; 0.22</td>
</tr>
<tr>
<td valign="top" align="left">Landrace</td>
<td valign="top" align="center">3.09 &#x000B1; 0.59</td>
<td valign="top" align="center">0.16 &#x000B1; 0.02</td>
<td valign="top" align="center">0.33 &#x000B1; 0.13</td>
<td valign="top" align="center">0.26 &#x000B1; 0.11</td>
<td valign="top" align="center">0.18 &#x000B1; 0.05</td>
<td valign="top" align="center">0.42 &#x000B1; 0.14</td>
</tr>
<tr>
<td valign="top" align="left"><italic>p</italic>-value</td>
<td valign="top" align="center"><italic>p</italic> &#x0003D; 0.0095</td>
<td valign="top" align="center"><italic>p</italic> &#x0003D; 0.0116</td>
<td valign="top" align="center"><italic>p</italic> &#x0003D; 0.0405</td>
<td valign="top" align="center"><italic>p</italic> &#x0003D; 0.0387</td>
<td valign="top" align="center"><italic>p</italic> &#x0003D; 0.0047</td>
<td valign="top" align="center"><italic>p</italic> &#x0003D; 0.0224</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>TLR9 mRNA expression in the DPL and landrace PBMCs</title>
<p>Because CpG ODN is an agonist for TLR9, we tested TLR9 gene expression in DPL and Landrace PBMCs with or without treatment with CpG ODN at different time points (Figure <xref ref-type="fig" rid="F5">5A</xref>). Without CpG ODN treatment, the DPL pigs had significantly higher mRNA levels of TLR9 than the Landrace pigs at 6 and 12 h (DPL/Landrace ratio 5.44- and 1.81-fold respectively); TLR9 mRNA levels in the DPL PBMCs treated with CpG ODN increased significantly at 12 and 24 h compared to control DPL PBMCs (2.33-, 5.61-fold); while TLR9 mRNA levels in the Landrace PBMCs increased significantly only at 24 h compared to the control Landrace PBMCs (2.7-fold). Furthermore, with CpG ODN treatment, the TLR9 mRNA level was significantly increased in the DPL PBMCs compared to the Landrace PBMCs at 24 h (3.51-fold). The data suggest that the DPL pigs had higher TLR9 mRNA levels in the PBMCs compared to Landrace pigs at early time points without CpG ODN treatment. TLR9 mRNA expression was more responsive to CpG ODN treatment in the DPL PBMCs compared to the Landrace PBMCs (based on the fact that the mRNA expression of TLR9 in the DPL PBMCs increased earlier than the Landrace PBMCs, and the expression level of TLR9 mRNA in the DPL PBMCs was significantly higher than that of the Landrace PBMCs).</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p><bold>TLR9 and cytokines gene expression in DPL and Landrace PBMCs after CpG ODN treatment</bold>. Gene expression of TLR9 and cytokines in stimulated DPL and Landrace PBMCs was assessed using qRT-PCR, the data were calculated by the 2<sup>&#x02212;&#x00394;&#x00394;CT</sup> method with B2M and PPIA as housekeeping genes. <bold>(A)</bold> TLR9, <bold>(B)</bold> IFN<sub>&#x003B1;</sub>, <bold>(C)</bold> IFN<sub>&#x003B3;</sub>, <bold>(D)</bold> CXCL8, <bold>(E)</bold> IL12 p(40). At the each time point of 6, 12, and 24 h, the un-stimulated DPL and Landrace pig PBMCs samples as negative control. Data represent the mean &#x000B1; SD from 6 different animals (<sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.05, <sup>&#x0002A;&#x0002A;</sup><italic>p</italic> &#x0003C; 0.01, <italic>Post-hoc</italic> test: Bonferroni-Holm). A, (Factor A &#x0003D; Breed); B, (Factor B &#x0003D; treatment); I, (Factor I &#x0003D; breed &#x000D7; treatment). C, control; T, treatment; L, Landrace; DPL, Dapulian.</p></caption>
<graphic xlink:href="fmicb-07-01992-g0005.tif"/>
</fig>
</sec>
<sec>
<title>Cytokine gene expression in the DPL and landrace PBMCs</title>
<p>Because large number of cytokine/chemokine genes were differentially expressed based on the RNA-seq result, we further studied their gene expression in the PBMCs of DPL and Landrace pigs after CpG ODN stimulation. The expression levels of IFN&#x003B1; and IFN&#x003B3; genes were significantly higher after 12 h stimulation with CpG ODN in both breeds (25.47-, 10.89-fold); moreover, the gene expression levels of IFN&#x003B1; was significantly higher in the DPL than the Landrace pigs at 12 h (2.64-fold) (Figures <xref ref-type="fig" rid="F5">5B,C</xref>). IL8 (CXCL8) mRNA level was significantly increased in both DPL and Landrace breeds after stimulation with CpG ODN at 12 h (10.89-, 3.80-fold). The DPL pigs had significantly higher IL8 mRNA level than the Landrace pigs at 12 h after stimulation with CpG ODN (2.37-fold). Two-way ANOVA demonstrated a significant effect of both breed and CpG ODN treatment on IL8 gene expression, and there was also a significant interaction between these two factors on IL8 gene expression (Figure <xref ref-type="fig" rid="F5">5D</xref>). After stimulation at 12 h, the expression level of IL12 p40 gene was significantly higher in the DPL pigs than the Landrace pigs (4.89-fold) (Figure <xref ref-type="fig" rid="F5">5E</xref>). Two-way ANOVA demonstrated a significant effect of both breed and CpG ODN treatment on IL12 p40 gene expression; and there was a significant interaction between these two factors on the expression of IL12 p40 gene. The data suggest that both breed and CpG ODN treatment had significant effect on TLR9 signaling.</p>
</sec>
<sec>
<title>Chemokine gene expression in the DPL and landrace PBMCs</title>
<p>After stimulation with CpG ODN, the expression levels of CXCL9 and CXCL13 genes were significantly higher in the DPL pigs compared to the Landrace pigs at 24 h (15.00-, 10.9-fold; Figures <xref ref-type="fig" rid="F6">6A,C</xref>). After stimulation with CpG ODN, both breeds had significantly increased levels of CXCL10 gene at 12 h (39.77-, 43.38-fold) and 24 h (29.75-, 13.06-fold) for DPL and Landrace respectively (Figure <xref ref-type="fig" rid="F6">6B</xref>). CCL19 gene was significantly higher in the DPL pigs 12 h after stimulation (4.93-fold). However, no significant CCL19 gene expression change was found in the Landrace pigs at any time points with or without CpG treatment (Figure <xref ref-type="fig" rid="F6">6D</xref>).</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p><bold>Chemokine genes expression in DPL and Landrace PBMCs after CpG ODN treatment</bold>. Gene expression of chemokine in stimulated DPL and Landrace PBMCs was assessed using qRT-PCR, the data were calculated by the 2<sup>&#x02212;&#x00394;&#x00394;CT</sup> method with B2M and PPIA as housekeeping genes. <bold>(A)</bold> CXCL9, <bold>(B)</bold> CXCl10, <bold>(C)</bold> CXCL13, <bold>(D)</bold> CCL19. At the each time point of 6, 12, and 24 h, the un-stimulated DPL and Landrace pig PBMCs samples as negative control. Data represent the mean &#x000B1; SD from 6 different animals (<sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.05, <sup>&#x0002A;&#x0002A;</sup><italic>p</italic> &#x0003C; 0.01, <italic>Post-hoc</italic> test: Bonferroni-Holm). A, (Factor A &#x0003D; Breed); B, (Factor B &#x0003D; treatment); I, (Factor I &#x0003D; breed &#x000D7; treatment). C &#x0003D; Control; T &#x0003D; treatment; L &#x0003D; Landrace; DPL &#x0003D; Dapulian.</p></caption>
<graphic xlink:href="fmicb-07-01992-g0006.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In this study, the transcriptional differences in the whole blood samples of DPL and Landrace pigs after a TLR9 agonist treatment were studied both <italic>in vivo</italic> and <italic>in vitro</italic>. CpG ODN has been used previously to stimulate pig immune system (Auray et al., <xref ref-type="bibr" rid="B3">2010</xref>; Dar et al., <xref ref-type="bibr" rid="B14">2010</xref>). Overall, there were significant differences in the whole blood gene expression between DPL and Landrace pigs. For example, the RNA-seq results showed that there were 500 DEGs in the whole blood between these two breeds after CpG ODN stimulation. The large number of DEGs identified suggest that the DPL and Landrace pigs responded to CpG ODN stimulation quite differently. Many identified DEGs were immune-relevant, which was in agreement with the immunostimulatory effect of CpG ODN treatment. Further bioinformatics analysis showed that these DEGs were enriched in the cytokine and chemokine signaling pathways, suggesting that cytokines and chemokines were important mediators for TLR signaling. Most immune-relevant DEGs had higher expression in the DPL pigs compared to the Landrace pigs (82.8 vs. 17.2%). The large proportion of immune-relevant DEGs with higher expression in the DPL pigs suggest that DPL pigs elicit a stronger immune reaction after CpG ODN treatment, which may help to explain its stronger disease resistance.</p>
<p>We next studied TLR9 gene expression in the PBMCs of DPL and Landrace pigs treated with CpG ODN <italic>in vitro</italic>. TLRs are critical components of the innate immune system. Moreover engagement of these receptors may affect the type of acquired immunity. It has been shown that TLR polymorphism or their expression level may confer disease resistance in different animal species or different pig breeds (Uenishi et al., <xref ref-type="bibr" rid="B51">2011</xref>; Yang et al., <xref ref-type="bibr" rid="B58">2013</xref>). The activation of TLRs by different agonists have been shown as potential therapeutic reagents for a number of diseases (McInturff et al., <xref ref-type="bibr" rid="B34">2005</xref>). Toll-like receptors are the best characterized pattern recognition receptor and are recognized as the major sensors of pathogens. After activation by TLR agonist, the nuclear factor-&#x003BA;B (NF-&#x003BA;B) was activated to regulate immune response and inflammation through MyD88 dependent or independent pathways (Barton and Medzhitov, <xref ref-type="bibr" rid="B5">2003</xref>; Kawai and Akira, <xref ref-type="bibr" rid="B25">2010</xref>). Therefore, understanding the molecular mechanism of TLR activation pattern in different pig breeds will provide a great promise for porcine disease resistance genetic improvement. TLR9 recognizes unmethylated CpG motifs, and then induces the recruitment of MyD88 to initiate downstream signaling (Takeshita et al., <xref ref-type="bibr" rid="B45">2004</xref>). Furthermore, it has been shown that TLR9 associates with MyD88 to initiate CpG ODN mediated effects via signal-transducing pathways including NF-&#x003BA;B, p38 MAPK, JNK, AP-1, and ATF-2 (Akira et al., <xref ref-type="bibr" rid="B1">2001</xref>; Osawa et al., <xref ref-type="bibr" rid="B41">2006</xref>; Zhang et al., <xref ref-type="bibr" rid="B60">2013</xref>). PBMCs express a wide range of TLRs and are crucial targets for various pathogens. The TLR9 ligand CpG ODN was shown to provide protection against infectious diseases (Manuja et al., <xref ref-type="bibr" rid="B32">2013</xref>). Our data showed that TLR9 mRNA had a higher expression level in the DPL pigs compared to the Landrace pigs without CpG ODN treatment <italic>in vitro</italic>. TLR9 mRNA levels in the DPL PBMCs were more responsive to CpG ODN treatment than the Landrace PBMCs. Even though the Landrace TLR9 mRNA was significantly increased at 24 h post CpG ODN treatment, it was still significantly lower than the DPL pigs. These results suggest that the two breeds have differences in sensitivity to CpG ODN treatment. The higher level of TLR9 mRNA and its responsiveness to CpG ODN treatment in DPL (a pig breed resistant to PRRS) is in agreement with literature showing that higher TLR levels were associated with disease resistance (Oliveira et al., <xref ref-type="bibr" rid="B38">2004</xref>; Karnati et al., <xref ref-type="bibr" rid="B24">2014</xref>; Cheng et al., <xref ref-type="bibr" rid="B10">2015</xref>). Surprisingly, TLR9 mRNA level was not found to be significantly different between the two breeds in the RNA-seq dataset, which was not in agreement with the PBMCs <italic>in vitro</italic> results. A possible explanation is that the <italic>in vitro</italic> experimental condition for PBMCs was different from the <italic>in vivo</italic> whole blood because PBMCs missing many medium present in the plasma. Moreover, the intercellular relationship between immunocompetent cells may have changed after PBMC separation. For example, it has been shown that the gene expression levels were different in the whole blood and PBMCs after stimulation with agonists (Groote et al., <xref ref-type="bibr" rid="B19">1992</xref>).</p>
<p>MyD88 is an essential adapter for TLR9 signaling (Takeshita et al., <xref ref-type="bibr" rid="B45">2004</xref>). Our data showed that the Landrace pigs had significantly higher expression of Myd88 mRNA in the whole blood than the DPL pigs. Previous studies have shown that there were great variability in gene mRNA expression in the same tissues of different pig breeds (Yu et al., <xref ref-type="bibr" rid="B59">2010</xref>; Sodhi et al., <xref ref-type="bibr" rid="B43">2014</xref>). Substantial inter-individual variation between pigs and the small sample number in this study may also influence the DEGs identified. Moreover, in our study, we only compared the RNA-seq data with the CpG ODN stimulation, lacking the data without CpG ODN treatment in the two breeds. Therefore, there is a possibility that DPL pigs have higher baseline TLR9 signaling.</p>
<p>Cytokines are cell-signaling proteins, which play crucial roles in haematopoiesis, inflammation and clearance of pathogens (Turner et al., <xref ref-type="bibr" rid="B49">2014</xref>). IFN&#x003B1;, a type I interferon, is a key cytokine of the host innate immune system to control virus infection (Biron, <xref ref-type="bibr" rid="B7">1998</xref>). IL8, also known as CXCL8, which plays important roles in the recruitment of neutrophils, chemotactic migration and activation of monocytes, lymphocytes, basophils, and eosinophils at the sites of inflammation (Turner et al., <xref ref-type="bibr" rid="B49">2014</xref>). In addition, IL12 p40 is a subunit of IL12 but also of IL23, plays a critical role in cell-mediated immunity (Oppmann et al., <xref ref-type="bibr" rid="B39">2000</xref>; Vignali and Kuchroo, <xref ref-type="bibr" rid="B52">2012</xref>). In this study, we showed that the gene expression levels of IFN &#x003B1; (2.64-fold), IL8 (2.37-fold), and IL12 p40 (4.89-fold) were significantly higher in DPL than Landrace pigs after stimulating PBMCs with CpG ODN. Other studies showed that the gene expression levels of IFN &#x003B1;, IL8, and IL12 p40 were significantly higher after stimulation with CpG ODN or infection with pathogens in swine (Dar et al., <xref ref-type="bibr" rid="B14">2010</xref>; Borghetti et al., <xref ref-type="bibr" rid="B8">2012</xref>; Liang et al., <xref ref-type="bibr" rid="B27">2016</xref>). Therefore, the significantly higher levels of theses cytokines in DPL pigs may play crucial roles in DPL disease resistance.</p>
<p>Chemokines are a group of small (8&#x02013;12 kDa) proteins, and characterized by cysteine residues and separated into two groups depending on the presence (C-X-C family) or absence (CC family) of an intervening amino acid between cysteine residues (Turner et al., <xref ref-type="bibr" rid="B49">2014</xref>). In the chemokines we studied in the PBMCs, CXCL9 (15.00-fold), and CXCL13 (10.9-fold) genes had significantly higher levels in the DPL pigs than the Landrace pigs, which is in agreement with the higher TLR9 levels in the DPL pigs. CXCL9 is a T-cell chemoattractant (Gorbachev et al., <xref ref-type="bibr" rid="B18">2007</xref>; Hertenstein et al., <xref ref-type="bibr" rid="B21">2011</xref>), which is secreted by all kinds of cell types including neutrophils, monocytes, endothelial cells and fibroblasts (Taub et al., <xref ref-type="bibr" rid="B47">1993</xref>). Studies have shown that in the setting of disease or stimulation with pre-inflammatory cytokines, the level of CXCL9 was increased (Coma et al., <xref ref-type="bibr" rid="B12">2006</xref>; Ohta et al., <xref ref-type="bibr" rid="B37">2008</xref>). C-X-C motif chemokine 13 (CXCL13), also known as B lymphocyte chemoattractant is a homeostatic chemokine that is constitutively expressed in secondary lymphoid tissue and involved in lymphoid organogenesis (Carlsen et al., <xref ref-type="bibr" rid="B9">2004</xref>). When in pathological status of adult-onset Still&#x00027;s disease, the production of CXCL13 was up-regulated, and it was regarded as a crucial chemokine in the establishment of the adaptive immune response in the pathogenesis (Han et al., <xref ref-type="bibr" rid="B20">2015</xref>). Therefore, the significantly higher levels of CXCL9 and CXCL13 mRNA in the DPL pigs after stimulation with CpG ODN may play important roles in DPL disease resistance. CXCL10 was significantly increased in the two breeds after stimulation, which is agreement with other studies showing that the CXCL10 is a reliable biomarker for immune activity induced by CpG ODN in pigs (Dar et al., <xref ref-type="bibr" rid="B14">2010</xref>). Moreover, Landrace pigs seem to be more responsive at 6 and 12 h, while DPL pigs seem to be more responsive at 24 h. Due to the individual variation, no significant differences was found in the two breeds for CXCL10 gene <italic>in vitro</italic> after stimulation. The significantly higher levels of CXCL10 in the DPL pigs may play an important role in DPL disease resistance. Previous studies have shown that CXCL10 is a reliable biomarker for immune system activity induced by CpG ODN in pigs (Dar et al., <xref ref-type="bibr" rid="B14">2010</xref>). Moreover, alterations in CXCL10 expression levels have been associated with inflammatory diseases including infection, immune dysfunction and tumor development (Liu M. et al., <xref ref-type="bibr" rid="B28">2011</xref>). Therefore, CXCL10 is also recognized as a biomarker that predicts severity of various infections (Liu M. et al., <xref ref-type="bibr" rid="B28">2011</xref>). Our results imply that TLR9 may elicit a stronger immune reaction through the induction of the above cytokines/chemokines. Hence, further studies are needed to explore the downstream and upstream signaling pathways regulating chemokines and their receptors ligands, particularly CXCL10 and their receptor ligands CXCR3, with the aim to exploit new methods to control infectious diseases mediated by theses chemokines.</p>
<p>To summarize, our data suggest that DPL pigs exhibited more responsiveness to CpG ODN stimulation than Landrace pigs. Regulating TLR9 mRNA levels in pigs might be a novel way to improve their immune capacity. The TLR9 mRNA levels may be regulated either using pharmacological methods or by guided breeding to select pig breeds with higher TLR9.</p>
</sec>
<sec id="s5">
<title>Author contributions</title>
<p>YZ, WC, and JH designed this study. JH, DY, and WC took samples and performed the experiments, and analyses. YZ, WC, JH, and HW write and revised this manuscript. JH, DY, and CL modificated the manuscript.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
</sec>
</body>
<back>
<ack><p>This study was supported by the National Animal Breed Resource Preservation Project of China (No. 2130135), the National Project for Breeding Transgenic Pigs of China (No. 2013ZX08006-002), Shandong Province Modern Pig Technology and Industry System Project (No. SDAIT-08-02), Shandong Province Agricultural Animal Breeding Project of China (No. 2013LZ02-015, 2014LZ03-016).</p>
</ack>
<sec sec-type="supplementary-material" id="s6">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fmicb.2016.01992/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fmicb.2016.01992/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table1.XLSX" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akira</surname> <given-names>S.</given-names></name> <name><surname>Takeda</surname> <given-names>K.</given-names></name> <name><surname>Kaisho</surname> <given-names>T.</given-names></name></person-group> (<year>2001</year>). <article-title>Toll-like receptors: critical proteins linking innate and acquired immunity</article-title>. <source>Nat. Immunol.</source> <volume>2</volume>, <fpage>675</fpage>&#x02013;<lpage>680</lpage>. <pub-id pub-id-type="doi">10.1038/90609</pub-id><pub-id pub-id-type="pmid">11477402</pub-id></citation>
</ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname> <given-names>S.</given-names></name> <name><surname>Huber</surname> <given-names>W.</given-names></name></person-group> (<year>2010</year>). <article-title>Differential expression analysis for sequence count data</article-title>. <source>Genome Biol.</source> <volume>11</volume>:<fpage>R106</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2010-11-10-r106</pub-id><pub-id pub-id-type="pmid">20979621</pub-id></citation>
</ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Auray</surname> <given-names>G.</given-names></name> <name><surname>Facci</surname> <given-names>M. R.</given-names></name> <name><surname>Kessel</surname> <given-names>J. V.</given-names></name> <name><surname>Buchanan</surname> <given-names>R.</given-names></name> <name><surname>Babiuk</surname> <given-names>L. A.</given-names></name> <name><surname>Gerdts</surname> <given-names>V.</given-names></name></person-group> (<year>2010</year>). <article-title>Differential activation and maturation of two porcine DC populations following TLR ligand stimulation</article-title>. <source>Mol. Immunol.</source> <volume>47</volume>, <fpage>2103</fpage>&#x02013;<lpage>2111</lpage>. <pub-id pub-id-type="doi">10.1016/j.molimm.2010.03.016</pub-id><pub-id pub-id-type="pmid">20462636</pub-id></citation>
</ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Auray</surname> <given-names>G.</given-names></name> <name><surname>Facci</surname> <given-names>M. R.</given-names></name> <name><surname>Van</surname> <given-names>K. J.</given-names></name> <name><surname>Buchanan</surname> <given-names>R.</given-names></name> <name><surname>Babiuk</surname> <given-names>L. A.</given-names></name> <name><surname>Gerdts</surname> <given-names>V.</given-names></name></person-group> (<year>2013</year>). <article-title>Porcine neonatal blood dendritic cells, but not monocytes, are more responsive to TLRs stimulation than their adult counterparts</article-title>. <source>PLoS ONE</source> <volume>8</volume>:<fpage>e59629</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0059629</pub-id></citation>
</ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barton</surname> <given-names>G. M.</given-names></name> <name><surname>Medzhitov</surname> <given-names>R.</given-names></name></person-group> (<year>2003</year>). <article-title>Toll-like receptor signaling pathways</article-title>. <source>Science</source> <volume>300</volume>, <fpage>1524</fpage>&#x02013;<lpage>1525</lpage>. <pub-id pub-id-type="doi">10.1126/science.1085536</pub-id><pub-id pub-id-type="pmid">12791976</pub-id></citation>
</ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhanothu</surname> <given-names>V.</given-names></name> <name><surname>Lakshmi</surname> <given-names>V.</given-names></name> <name><surname>Theophilus</surname> <given-names>J. P.</given-names></name> <name><surname>Rozati</surname> <given-names>R.</given-names></name> <name><surname>Badhini</surname> <given-names>P.</given-names></name> <name><surname>Vijayalaxmi</surname> <given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>Investigation of toll-like receptor-2 (2258G/A) and interferon gamma (&#x0002B;874T/A) gene polymorphisms among infertile women with female genital Tuberculosis</article-title>. <source>PLoS ONE</source> <volume>10</volume>:<fpage>e130273</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0130273</pub-id><pub-id pub-id-type="pmid">26114934</pub-id></citation>
</ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Biron</surname> <given-names>C. A.</given-names></name></person-group> (<year>1998</year>). <article-title>Role of early cytokines, including alpha and beta interferons (IFN-&#x003B1;&#x003B2;), in innate and adaptive immune responses to viral infections</article-title>. <source>Semin. Immunol.</source> <volume>10</volume>, <fpage>383</fpage>&#x02013;<lpage>390</lpage>. <pub-id pub-id-type="doi">10.1006/smim.1998.0138</pub-id></citation>
</ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Borghetti</surname> <given-names>P.</given-names></name> <name><surname>Morganti</surname> <given-names>M.</given-names></name> <name><surname>Saleri</surname> <given-names>R.</given-names></name> <name><surname>Ferrari</surname> <given-names>L.</given-names></name> <name><surname>De Angelis</surname> <given-names>E.</given-names></name> <name><surname>Cavalli</surname> <given-names>V.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Innate pro-inflammatory and adaptive immune cytokines in PBMC of vaccinated and unvaccinated pigs naturally exposed to porcine circovirus type 2 (PCV2) infection vary with the occurrence of the disease and the viral burden</article-title>. <source>Vet. Microbiol.</source> <volume>163</volume>, <fpage>42</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetmic.2012.12.007</pub-id><pub-id pub-id-type="pmid">23290117</pub-id></citation>
</ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carlsen</surname> <given-names>H. S.</given-names></name> <name><surname>Baekkevold</surname> <given-names>E. S.</given-names></name> <name><surname>Morton</surname> <given-names>H. C.</given-names></name> <name><surname>Haraldsen</surname> <given-names>G.</given-names></name> <name><surname>Brandtzaeg</surname> <given-names>P.</given-names></name></person-group> (<year>2004</year>). <article-title>Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis</article-title>. <source>Blood</source> <volume>104</volume>, <fpage>3021</fpage>&#x02013;<lpage>3027</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2004-02-0701</pub-id><pub-id pub-id-type="pmid">15284119</pub-id></citation>
</ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>C.</given-names></name> <name><surname>Sun</surname> <given-names>W. K.</given-names></name> <name><surname>Liu</surname> <given-names>R.</given-names></name> <name><surname>Wang</surname> <given-names>R. M.</given-names></name> <name><surname>Chen</surname> <given-names>Y. H.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Comparison of gene expression of Toll-like receptors and antimicrobial peptides in immune organs and tissues between Yorkshire and Tibetan pigs</article-title>. <source>Anim. Genet.</source> <volume>46</volume>, <fpage>272</fpage>&#x02013;<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1111/age.12286</pub-id><pub-id pub-id-type="pmid">25917299</pub-id></citation>
</ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cinar</surname> <given-names>M. U.</given-names></name> <name><surname>Islam</surname> <given-names>M. A.</given-names></name> <name><surname>Pr&#x000F6;ll</surname> <given-names>M.</given-names></name> <name><surname>Kocamis</surname> <given-names>H.</given-names></name> <name><surname>Tholen</surname> <given-names>E.</given-names></name> <name><surname>Tesfaye</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Evaluation of suitable reference genes for gene expression studies in porcine PBMCs in response to LPS and LTA</article-title>. <source>BMC Res. Notes</source> <volume>6</volume>:<fpage>56</fpage>. <pub-id pub-id-type="doi">10.1186/1756-0500-6-56</pub-id><pub-id pub-id-type="pmid">23394600</pub-id></citation>
</ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coma</surname> <given-names>G.</given-names></name> <name><surname>Pe&#x000F1;a</surname> <given-names>R.</given-names></name> <name><surname>Blanco</surname> <given-names>J.</given-names></name> <name><surname>Rosell</surname> <given-names>A.</given-names></name> <name><surname>Borras</surname> <given-names>F. E.</given-names></name> <name><surname>Est&#x000E9;</surname> <given-names>J. A.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Treatment of monocytes with interleukin (IL)-12 plus IL-18 stimulates survival, differentiation and the production of CXC chemokine ligands (CXCL)8, CXCL9 and CXCL10</article-title>. <source>Clin. Exp. Immunol.</source> <volume>145</volume>, <fpage>535</fpage>&#x02013;<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.2006.03145.x</pub-id><pub-id pub-id-type="pmid">16907924</pub-id></citation>
</ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Conesa</surname> <given-names>A.</given-names></name> <name><surname>G&#x000F6;tz</surname> <given-names>S.</given-names></name> <name><surname>Garc&#x000ED;a-G&#x000F3;mez</surname> <given-names>J. M.</given-names></name> <name><surname>Terol</surname> <given-names>J.</given-names></name> <name><surname>Tal&#x000F3;n</surname> <given-names>M.</given-names></name> <name><surname>Robles</surname> <given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research</article-title>. <source>Bioinformatics</source> <volume>21</volume>, <fpage>3674</fpage>&#x02013;<lpage>3676</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bti610</pub-id><pub-id pub-id-type="pmid">16081474</pub-id></citation>
</ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dar</surname> <given-names>A.</given-names></name> <name><surname>Nichani</surname> <given-names>A.</given-names></name> <name><surname>Lai</surname> <given-names>K.</given-names></name> <name><surname>Potter</surname> <given-names>A.</given-names></name> <name><surname>Gerdts</surname> <given-names>V.</given-names></name> <name><surname>Babiuk</surname> <given-names>L. A.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>All three classes of CpG ODNs up-regulate IP-10 gene in pigs</article-title>. <source>Res. Vet. Sci.</source> <volume>88</volume>, <fpage>242</fpage>&#x02013;<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1016/j.rvsc.2009.10.003</pub-id><pub-id pub-id-type="pmid">19896155</pub-id></citation>
</ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Du</surname> <given-names>Y.</given-names></name> <name><surname>Du</surname> <given-names>T.</given-names></name> <name><surname>Shi</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>A.</given-names></name> <name><surname>Zhang</surname> <given-names>C.</given-names></name> <name><surname>Diao</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Synthetic Toll-like receptor 7 ligand inhibits porcine reproductive and respiratory syndrome virus infection in primary porcine alveolar macrophages</article-title>. <source>Antivir. Res.</source> <volume>131</volume>, <fpage>9</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2016.04.005</pub-id><pub-id pub-id-type="pmid">27079946</pub-id></citation>
</ref>
<ref id="B16">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Fuss</surname> <given-names>I. J.</given-names></name> <name><surname>Kanof</surname> <given-names>M. E.</given-names></name> <name><surname>Smith</surname> <given-names>P. D.</given-names></name> <name><surname>Zola</surname> <given-names>H.</given-names></name></person-group> (<year>2009</year>). <source>Isolation of Whole Mononuclear Cells from Peripheral Blood and Cord Blood.</source> <publisher-loc>Bethesda, MD</publisher-loc>: <publisher-name>Wiley Online Library</publisher-name>.</citation>
</ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname> <given-names>M.</given-names></name> <name><surname>Sodhi</surname> <given-names>S.</given-names></name> <name><surname>Song</surname> <given-names>K. D.</given-names></name> <name><surname>Kim</surname> <given-names>J.</given-names></name> <name><surname>Mongre</surname> <given-names>R.</given-names></name> <name><surname>Sharma</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Evaluation of body growth and immunity-related differentially expressed genes through deep RNA sequencing in the piglets of Jeju native pig and Berkshire</article-title>. <source>Anim. Genet.</source> <volume>46</volume>, <fpage>255</fpage>&#x02013;<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1111/age.12281</pub-id><pub-id pub-id-type="pmid">25752324</pub-id></citation>
</ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gorbachev</surname> <given-names>A. V.</given-names></name> <name><surname>Kobayashi</surname> <given-names>H.</given-names></name> <name><surname>Kudo</surname> <given-names>D.</given-names></name> <name><surname>Tannenbaum</surname> <given-names>C. S.</given-names></name> <name><surname>Finke</surname> <given-names>J. H.</given-names></name> <name><surname>Shu</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors</article-title>. <source>J. Immunol.</source> <volume>178</volume>, <fpage>2278</fpage>&#x02013;<lpage>2286</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.178.4.2278</pub-id><pub-id pub-id-type="pmid">17277133</pub-id></citation>
</ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Groote</surname> <given-names>D. D.</given-names></name> <name><surname>Zangerle</surname> <given-names>P. F.</given-names></name> <name><surname>Gevaert</surname> <given-names>Y.</given-names></name> <name><surname>Fassotte</surname> <given-names>M. F.</given-names></name> <name><surname>Beguin</surname> <given-names>Y.</given-names></name> <name><surname>Noizat-Pirenne</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>1992</year>). <article-title>Direct stimulation of cytokines (IL-1&#x003B2;, TNF-&#x003B1;, IL-6, IL-2, IFN-&#x003B3; and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation</article-title>. <source>Cytokine</source> <volume>4</volume>, <fpage>239</fpage>&#x02013;<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1016/1043-4666(92)90062-V</pub-id></citation>
</ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>J. H.</given-names></name> <name><surname>Suh</surname> <given-names>C. H.</given-names></name> <name><surname>Jung</surname> <given-names>J. Y.</given-names></name> <name><surname>Nam</surname> <given-names>J. Y.</given-names></name> <name><surname>Kwon</surname> <given-names>J. E.</given-names></name> <name><surname>Yim</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still&#x00027;s disease</article-title>. <source>Arthritis Res. Ther.</source> <volume>17</volume>, <fpage>1</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1186/s13075-015-0773-4</pub-id><pub-id pub-id-type="pmid">26385705</pub-id></citation>
</ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hertenstein</surname> <given-names>A.</given-names></name> <name><surname>Schumacher</surname> <given-names>T.</given-names></name> <name><surname>Litzenburger</surname> <given-names>U.</given-names></name> <name><surname>Opitz</surname> <given-names>C. A.</given-names></name> <name><surname>Falk</surname> <given-names>C. S.</given-names></name> <name><surname>Serafini</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Suppression of human CD4&#x0002B; T cell activation by 3,4-dimethoxycinnamonyl-anthranilic acid (tranilast) is mediated by CXCL9 and CXCL10</article-title>. <source>Biochem. Pharmacol.</source> <volume>82</volume>, <fpage>632</fpage>&#x02013;<lpage>641</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2011.06.013</pub-id><pub-id pub-id-type="pmid">21703247</pub-id></citation>
</ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>Y.</given-names></name> <name><surname>Cong</surname> <given-names>X.</given-names></name> <name><surname>Chen</surname> <given-names>L.</given-names></name> <name><surname>Qi</surname> <given-names>J.</given-names></name> <name><surname>Wu</surname> <given-names>X.</given-names></name> <name><surname>Zhou</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Synergy of TLR3 and 7 ligands significantly enhances function of DCs to present inactivated PRRSV antigen through TRIF/MyD88-NF-&#x003BA;B signaling pathway</article-title>. <source>Sci. Rep.</source> <volume>6</volume>:<fpage>23977</fpage>. <pub-id pub-id-type="doi">10.1038/srep23977</pub-id><pub-id pub-id-type="pmid">27046485</pub-id></citation>
</ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>C.</given-names></name> <name><surname>Xing</surname> <given-names>F.</given-names></name> <name><surname>Xing</surname> <given-names>J.</given-names></name> <name><surname>Jiang</surname> <given-names>Y.</given-names></name> <name><surname>Zhou</surname> <given-names>E.</given-names></name></person-group> (<year>2013</year>). <article-title>Different expression patterns of PRRSV mediator genes in the lung tissues of PRRSV resistant and susceptible pigs</article-title>. <source>Dev. Comp. Immunol.</source> <volume>39</volume>, <fpage>127</fpage>&#x02013;<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1016/j.dci.2012.01.003</pub-id><pub-id pub-id-type="pmid">22305867</pub-id></citation>
</ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karnati</surname> <given-names>H. K.</given-names></name> <name><surname>Pasupuleti</surname> <given-names>S. R.</given-names></name> <name><surname>Kandi</surname> <given-names>R.</given-names></name> <name><surname>Undi</surname> <given-names>R. B.</given-names></name> <name><surname>Sahu</surname> <given-names>I.</given-names></name> <name><surname>Kannaki</surname> <given-names>T. R.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>TLR-4 signalling pathway: myD88 independent pathway up-regulation in chicken breeds upon LPS treatment</article-title>. <source>Vet. Res. Commun.</source> <volume>39</volume>, <fpage>73</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1007/s11259-014-9621-2</pub-id><pub-id pub-id-type="pmid">25417198</pub-id></citation>
</ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname> <given-names>T.</given-names></name> <name><surname>Akira</surname> <given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors</article-title>. <source>Nat. Immunol.</source> <volume>11</volume>, <fpage>373</fpage>&#x02013;<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1038/ni.1863</pub-id><pub-id pub-id-type="pmid">20404851</pub-id></citation>
</ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>H.</given-names></name> <name><surname>Kawai</surname> <given-names>T.</given-names></name> <name><surname>Akira</surname> <given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Pathogen recognition in the innate immune response</article-title>. <source>Biochem. J.</source> <volume>420</volume>, <fpage>1</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20090272</pub-id><pub-id pub-id-type="pmid">19382893</pub-id></citation>
</ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname> <given-names>W.</given-names></name> <name><surname>Li</surname> <given-names>Z.</given-names></name> <name><surname>Wang</surname> <given-names>P.</given-names></name> <name><surname>Fan</surname> <given-names>P.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>Q.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Differences of immune responses between Tongcheng (Chinese local breed) and Large White pigs after artificial infection with highly pathogenic porcine reproductive and respiratory syndrome virus</article-title>. <source>Virus Res.</source> <volume>215</volume>, <fpage>84</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.virusres.2016.02.004</pub-id><pub-id pub-id-type="pmid">26878768</pub-id></citation>
</ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>M.</given-names></name> <name><surname>Guo</surname> <given-names>S.</given-names></name> <name><surname>Hibbert</surname> <given-names>J. M.</given-names></name> <name><surname>Jain</surname> <given-names>V.</given-names></name> <name><surname>Singh</surname> <given-names>N.</given-names></name> <name><surname>Wilson</surname> <given-names>N. O.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications</article-title>. <source>Cytokine Growth Factor Rev.</source> <volume>22</volume>, <fpage>121</fpage>&#x02013;<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1016/j.cytogfr.2011.06.001</pub-id><pub-id pub-id-type="pmid">21802343</pub-id></citation>
</ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Chang</surname> <given-names>G. B.</given-names></name> <name><surname>Hu</surname> <given-names>G. S.</given-names></name> <name><surname>Li</surname> <given-names>Q.</given-names></name> <name><surname>Xu</surname> <given-names>Q.</given-names></name> <name><surname>Chen</surname> <given-names>G. H.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Genetic variation at Exon2 of TLR4 gene and its association with resistant traits in chicken</article-title>. <source>Afr. J. Biotechnol.</source> <volume>10</volume>, <fpage>8260</fpage>&#x02013;<lpage>8266</lpage>. <pub-id pub-id-type="doi">10.5897/AJB10.2620</pub-id></citation>
</ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname> <given-names>K. J.</given-names></name> <name><surname>Schmittgen</surname> <given-names>T. D.</given-names></name></person-group> (<year>2001</year>). <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the <sup>2&#x02212;&#x00394;&#x00394;CT</sup> method</article-title>. <source>Methods</source> <volume>25</volume>, <fpage>402</fpage>&#x02013;<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id></citation>
</ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lunney</surname> <given-names>J. K.</given-names></name> <name><surname>Chen</surname> <given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>Genetic control of host resistance to porcine reproductive and respiratory syndrome virus (PRRSV) infection</article-title>. <source>Virus Res.</source> <volume>154</volume>, <fpage>161</fpage>&#x02013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/j.virusres.2010.08.004</pub-id><pub-id pub-id-type="pmid">20709118</pub-id></citation>
</ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manuja</surname> <given-names>A.</given-names></name> <name><surname>Manuja</surname> <given-names>B. K.</given-names></name> <name><surname>Kaushik</surname> <given-names>J.</given-names></name> <name><surname>Singha</surname> <given-names>H.</given-names></name> <name><surname>Singh</surname> <given-names>R. K.</given-names></name></person-group> (<year>2013</year>). <article-title>Immunotherapeutic potential of CpG oligodeoxynucleotides in veterinary species</article-title>. <source>Immunopharmacol. Immunotoxicol.</source> <volume>35</volume>, <fpage>535</fpage>&#x02013;<lpage>544</lpage>. <pub-id pub-id-type="doi">10.3109/08923973.2013.828743</pub-id><pub-id pub-id-type="pmid">23981003</pub-id></citation>
</ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martino</surname> <given-names>A.</given-names></name> <name><surname>Cabiati</surname> <given-names>M.</given-names></name> <name><surname>Campan</surname> <given-names>M.</given-names></name> <name><surname>Prescimone</surname> <given-names>T.</given-names></name> <name><surname>Minocci</surname> <given-names>D.</given-names></name> <name><surname>Caselli</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Selection of reference genes for normalization of real-time PCR data in minipig heart failure model and evaluation of TNF-&#x003B1; mRNA expression</article-title>. <source>J. Biotechnol.</source> <volume>153</volume>, <fpage>92</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiotec.2011.04.002</pub-id><pub-id pub-id-type="pmid">21510983</pub-id></citation>
</ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McInturff</surname> <given-names>J. E.</given-names></name> <name><surname>Modlin</surname> <given-names>R. L.</given-names></name> <name><surname>Kim</surname> <given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>The role of toll-like receptors in the pathogenesis and treatment of dermatological disease</article-title>. <source>J. Invest. Dermatol.</source> <volume>125</volume>, <fpage>1</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/j.0022-202X.2004.23459.x</pub-id><pub-id pub-id-type="pmid">15982296</pub-id></citation>
</ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname> <given-names>X.</given-names></name></person-group> (<year>2012</year>). <article-title>Emerging and re-emerging swine viruses</article-title>. <source>Transbound. Emerg. Dis.</source> <volume>59</volume>, <fpage>85</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1111/j.1865-1682.2011.01291.x</pub-id><pub-id pub-id-type="pmid">22225855</pub-id></citation>
</ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mu</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>M.</given-names></name> <name><surname>Ding</surname> <given-names>F.</given-names></name> <name><surname>Ding</surname> <given-names>Y.</given-names></name> <name><surname>Ao</surname> <given-names>J.</given-names></name> <name><surname>Hu</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title><italic>De novo</italic> characterization of the spleen transcriptome of the large yellow croaker (<italic>Pseudosciaena crocea</italic>) and analysis of the immune relevant genes and pathways involved in the antiviral response</article-title>. <source>PLoS ONE</source> <volume>9</volume>:<fpage>e97471</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0097471</pub-id><pub-id pub-id-type="pmid">24820969</pub-id></citation>
</ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohta</surname> <given-names>K.</given-names></name> <name><surname>Shigeishi</surname> <given-names>H.</given-names></name> <name><surname>Taki</surname> <given-names>M.</given-names></name> <name><surname>Nishi</surname> <given-names>H.</given-names></name> <name><surname>Higashikawa</surname> <given-names>K.</given-names></name> <name><surname>Takechi</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>Regulation of CXCL9/10/11 in oral keratinocytes and fibroblasts</article-title>. <source>J. Dent. Res.</source> <volume>87</volume>, <fpage>1160</fpage>&#x02013;<lpage>1165</lpage>. <pub-id pub-id-type="doi">10.1177/154405910808701211</pub-id><pub-id pub-id-type="pmid">19029086</pub-id></citation>
</ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname> <given-names>A. C.</given-names></name> <name><surname>Peixoto</surname> <given-names>J. R.</given-names></name> <name><surname>de Arruda</surname> <given-names>L. B.</given-names></name> <name><surname>Campos</surname> <given-names>M. A.</given-names></name> <name><surname>Gazzinelli</surname> <given-names>R. T.</given-names></name> <name><surname>Golenbock</surname> <given-names>D. T.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with <italic>T. cruzi</italic></article-title>. <source>J. Immunol.</source> <volume>173</volume>, <fpage>5688</fpage>&#x02013;<lpage>5696</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.173.9.5688</pub-id><pub-id pub-id-type="pmid">15494520</pub-id></citation>
</ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oppmann</surname> <given-names>B.</given-names></name> <name><surname>Lesley</surname> <given-names>R.</given-names></name> <name><surname>Blom</surname> <given-names>B.</given-names></name> <name><surname>Timans</surname> <given-names>J. C.</given-names></name> <name><surname>Xu</surname> <given-names>Y.</given-names></name> <name><surname>Hunte</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2000</year>). <article-title>Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12</article-title>. <source>Immunity</source> <volume>13</volume>, <fpage>715</fpage>&#x02013;<lpage>725</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-7613(00)00070-4</pub-id><pub-id pub-id-type="pmid">11114383</pub-id></citation>
</ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Opriessnig</surname> <given-names>T.</given-names></name> <name><surname>Fenaux</surname> <given-names>M.</given-names></name> <name><surname>Thomas</surname> <given-names>P.</given-names></name> <name><surname>Hoogland</surname> <given-names>M. J.</given-names></name> <name><surname>Rothschild</surname> <given-names>M. F.</given-names></name> <name><surname>Meng</surname> <given-names>X. J.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Evidence of breed-dependent differences in susceptibility to porcine circovirus type-2-associated disease and lesions</article-title>. <source>Vet. Pathol.</source> <volume>43</volume>, <fpage>281</fpage>&#x02013;<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1354/vp.43-3-281</pub-id><pub-id pub-id-type="pmid">16672575</pub-id></citation>
</ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Osawa</surname> <given-names>Y.</given-names></name> <name><surname>Iho</surname> <given-names>S.</given-names></name> <name><surname>Takauji</surname> <given-names>R.</given-names></name> <name><surname>Takatsuka</surname> <given-names>H.</given-names></name> <name><surname>Yamamoto</surname> <given-names>S.</given-names></name> <name><surname>Takahashi</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Collaborative action of NF-&#x003BA;B and p38 MAPK is involved in CpG DNA-induced IFN-&#x003B1; and chemokine production in human plasmacytoid dendritic cells</article-title>. <source>J. Immunol.</source> <volume>177</volume>, <fpage>4841</fpage>&#x02013;<lpage>4852</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.177.7.4841</pub-id><pub-id pub-id-type="pmid">16982926</pub-id></citation>
</ref>
<ref id="B42">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reiner</surname> <given-names>G.</given-names></name> <name><surname>Melchinger</surname> <given-names>E.</given-names></name> <name><surname>Kramarova</surname> <given-names>M.</given-names></name> <name><surname>Pfaff</surname> <given-names>E.</given-names></name> <name><surname>B&#x000FC;ttner</surname> <given-names>M.</given-names></name> <name><surname>Saalm&#x000FC;ller</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>Detection of quantitative trait loci for resistance/susceptibility to pseudorabies virus in swine</article-title>. <source>J. Gen. Virol.</source> <volume>83</volume>, <fpage>167</fpage>&#x02013;<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1099/0022-1317-83-1-167</pub-id><pub-id pub-id-type="pmid">11752713</pub-id></citation>
</ref>
<ref id="B43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sodhi</surname> <given-names>S. S.</given-names></name> <name><surname>Park</surname> <given-names>W. C.</given-names></name> <name><surname>Ghosh</surname> <given-names>M.</given-names></name> <name><surname>Kim</surname> <given-names>J. N.</given-names></name> <name><surname>Sharma</surname> <given-names>N.</given-names></name> <name><surname>Shin</surname> <given-names>K. Y.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Comparative transcriptomic analysis to identify differentially expressed genes in fat tissue of adult Berkshire and Jeju native pig using RNA-seq</article-title>. <source>Mol. Biol. Rep.</source> <volume>41</volume>, <fpage>6305</fpage>&#x02013;<lpage>6315</lpage>. <pub-id pub-id-type="doi">10.1007/s11033-014-3513-y</pub-id><pub-id pub-id-type="pmid">25008993</pub-id></citation>
</ref>
<ref id="B44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swiderek</surname> <given-names>W. P.</given-names></name> <name><surname>Bhide</surname> <given-names>M. R.</given-names></name> <name><surname>Gruszczy&#x00144;ska</surname> <given-names>J.</given-names></name> <name><surname>Soltis</surname> <given-names>K.</given-names></name> <name><surname>Witkowska</surname> <given-names>D.</given-names></name> <name><surname>Mikula</surname> <given-names>I.</given-names></name></person-group> (<year>2006</year>). <article-title>Toll-like receptor gene polymorphism and its relationship with somatic cell concentration and natural bacterial infections of the mammary gland in sheep</article-title>. <source>Folia Microbiol. (Praha).</source> <volume>51</volume>, <fpage>647</fpage>&#x02013;<lpage>652</lpage>. <pub-id pub-id-type="doi">10.1007/BF02931633</pub-id><pub-id pub-id-type="pmid">17455805</pub-id></citation>
</ref>
<ref id="B45">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Takeshita</surname> <given-names>F.</given-names></name> <name><surname>Gursel</surname> <given-names>I.</given-names></name> <name><surname>Ishii</surname> <given-names>K. J.</given-names></name> <name><surname>Suzuki</surname> <given-names>K.</given-names></name> <name><surname>Gursel</surname> <given-names>M.</given-names></name> <name><surname>Klinman</surname> <given-names>D. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9</article-title>, in <source>Seminars in immunology</source>, ed <person-group person-group-type="editor"><name><surname>Mantovani</surname> <given-names>A.</given-names></name></person-group> (<publisher-loc>Bethesda, MD</publisher-loc>: <publisher-name>Elsevier</publisher-name>), <fpage>17</fpage>&#x02013;<lpage>22</lpage>.</citation>
</ref>
<ref id="B46">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname> <given-names>O.</given-names></name> <name><surname>Akira</surname> <given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Pattern recognition receptors and inflammation</article-title>. <source>Cell</source> <volume>140</volume>, <fpage>805</fpage>&#x02013;<lpage>820</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.01.022</pub-id><pub-id pub-id-type="pmid">20303872</pub-id></citation>
</ref>
<ref id="B47">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taub</surname> <given-names>D. D.</given-names></name> <name><surname>Lloyd</surname> <given-names>A. R.</given-names></name> <name><surname>Conlon</surname> <given-names>K.</given-names></name> <name><surname>Wang</surname> <given-names>J. M.</given-names></name> <name><surname>Ortaldo</surname> <given-names>J. R.</given-names></name> <name><surname>Harada</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>1993</year>). <article-title>Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells</article-title>. <source>J. Exp. Med.</source> <volume>177</volume>, <fpage>1809</fpage>&#x02013;<lpage>1814</lpage>. <pub-id pub-id-type="doi">10.1084/jem.177.6.1809</pub-id><pub-id pub-id-type="pmid">8496693</pub-id></citation>
</ref>
<ref id="B48">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trapnell</surname> <given-names>C.</given-names></name> <name><surname>Williams</surname> <given-names>B. A.</given-names></name> <name><surname>Pertea</surname> <given-names>G.</given-names></name> <name><surname>Mortazavi</surname> <given-names>A.</given-names></name> <name><surname>Kwan</surname> <given-names>G.</given-names></name> <name><surname>van Baren</surname> <given-names>M. J.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation</article-title>. <source>Nat. Biotechnol.</source> <volume>28</volume>, <fpage>511</fpage>&#x02013;<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.1621</pub-id><pub-id pub-id-type="pmid">20436464</pub-id></citation>
</ref>
<ref id="B49">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname> <given-names>M. D.</given-names></name> <name><surname>Nedjai</surname> <given-names>B.</given-names></name> <name><surname>Hurst</surname> <given-names>T.</given-names></name> <name><surname>Pennington</surname> <given-names>D. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1843</volume>, <fpage>2563</fpage>&#x02013;<lpage>2582</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2014.05.014</pub-id><pub-id pub-id-type="pmid">24892271</pub-id></citation>
</ref>
<ref id="B50">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uenishi</surname> <given-names>H.</given-names></name> <name><surname>Shinkai</surname> <given-names>H.</given-names></name></person-group> (<year>2009</year>). <article-title>Porcine Toll-like receptors: the front line of pathogen monitoring and possible implications for disease resistance</article-title>. <source>Dev. Comp. Immunol.</source> <volume>33</volume>, <fpage>353</fpage>&#x02013;<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1016/j.dci.2008.06.001</pub-id><pub-id pub-id-type="pmid">18590761</pub-id></citation>
</ref>
<ref id="B51">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uenishi</surname> <given-names>H.</given-names></name> <name><surname>Shinkai</surname> <given-names>H.</given-names></name> <name><surname>Morozumi</surname> <given-names>T.</given-names></name> <name><surname>Muneta</surname> <given-names>Y.</given-names></name> <name><surname>Jozaki</surname> <given-names>K.</given-names></name> <name><surname>Kojimashibata</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Polymorphisms in pattern recognition receptors and their relationship to infectious disease susceptibility in pigs</article-title>. <source>BMC Proc.</source> <volume>5</volume>(<supplement>Suppl. 4</supplement>):<fpage>S27</fpage>. <pub-id pub-id-type="doi">10.1186/1753-6561-5-s4-s27</pub-id><pub-id pub-id-type="pmid">21645307</pub-id></citation>
</ref>
<ref id="B52">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vignali</surname> <given-names>D. A.</given-names></name> <name><surname>Kuchroo</surname> <given-names>V. K.</given-names></name></person-group> (<year>2012</year>). <article-title>IL-12 family cytokines: immunological playmakers</article-title>. <source>Nat. Immunol.</source> <volume>13</volume>, <fpage>722</fpage>&#x02013;<lpage>728</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2366</pub-id><pub-id pub-id-type="pmid">22814351</pub-id></citation>
</ref>
<ref id="B53">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Guo</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Lin</surname> <given-names>S.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Selection of reference genes and determination of cytokines and receptor mRNA expression in peripheral blood of piglets</article-title>. <source>Sci. Agric. Sin.</source> <volume>48</volume>, <fpage>1437</fpage>&#x02013;<lpage>1444</lpage>. <pub-id pub-id-type="doi">10.3864/j.issn.0578-1752.2015.07.18</pub-id></citation>
</ref>
<ref id="B54">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilhelm</surname> <given-names>B. T.</given-names></name> <name><surname>Landry</surname> <given-names>J.-R.</given-names></name></person-group> (<year>2009</year>). <article-title>RNA-Seq&#x02014;quantitative measurement of expression through massively parallel RNA-sequencing</article-title>. <source>Methods</source> <volume>48</volume>, <fpage>249</fpage>&#x02013;<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymeth.2009.03.016</pub-id><pub-id pub-id-type="pmid">19336255</pub-id></citation>
</ref>
<ref id="B55">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname> <given-names>J.</given-names></name> <name><surname>Zhong</surname> <given-names>H.</given-names></name> <name><surname>Liu</surname> <given-names>Z.</given-names></name> <name><surname>Yu</surname> <given-names>F.</given-names></name> <name><surname>Luo</surname> <given-names>Y.</given-names></name> <name><surname>Gan</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Transcriptome analysis revealed positive selection of immune-related genes in tilapia</article-title>. <source>Fish Shellfish Immunol.</source> <volume>44</volume>, <fpage>60</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.fsi.2015.01.022</pub-id><pub-id pub-id-type="pmid">25659230</pub-id></citation>
</ref>
<ref id="B56">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname> <given-names>J.</given-names></name> <name><surname>Xing</surname> <given-names>F.</given-names></name> <name><surname>Zhang</surname> <given-names>C.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>N.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Genome-wide gene expression profiles in lung tissues of pig breeds differing in resistance to porcine reproductive and respiratory syndrome virus</article-title>. <source>PLoS ONE</source> <volume>9</volume>:<fpage>e86101</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0086101</pub-id><pub-id pub-id-type="pmid">24465897</pub-id></citation>
</ref>
<ref id="B57">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>Livestock development in China: animal production, consumption and genetic resources</article-title>. <source>J. Anim. Breed. Genet.</source> <volume>130</volume>, <fpage>249</fpage>&#x02013;<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1111/jbg.12045</pub-id><pub-id pub-id-type="pmid">23855626</pub-id></citation>
</ref>
<ref id="B58">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>X.</given-names></name> <name><surname>Murani</surname> <given-names>E.</given-names></name> <name><surname>Ponsuksili</surname> <given-names>S.</given-names></name> <name><surname>Wimmers</surname> <given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>Association of TLR5 sequence variants and mRNA level with cytokine transcription in pigs</article-title>. <source>Immunogenetics</source> <volume>65</volume>, <fpage>125</fpage>&#x02013;<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1007/s00251-012-0662-9</pub-id><pub-id pub-id-type="pmid">23132291</pub-id></citation>
</ref>
<ref id="B59">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>G.</given-names></name> <name><surname>Flori</surname> <given-names>L.</given-names></name> <name><surname>Lecardonnel</surname> <given-names>J.</given-names></name> <name><surname>Esquerr&#x000E9;</surname> <given-names>D.</given-names></name> <name><surname>Hu</surname> <given-names>Z. L.</given-names></name> <name><surname>Teillaud</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Transcriptome analysis of porcine PBMCs after <italic>in vitro</italic> stimulation by LPS or PMA/ionomycin using an expression array targeting the pig immune response</article-title>. <source>BMC Genomics</source> <volume>11</volume>:<fpage>292</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2164-11-292</pub-id><pub-id pub-id-type="pmid">20459780</pub-id></citation>
</ref>
<ref id="B60">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>J.</given-names></name> <name><surname>Zhu</surname> <given-names>Q.</given-names></name> <name><surname>Huang</surname> <given-names>P.</given-names></name> <name><surname>Yu</surname> <given-names>Q.</given-names></name> <name><surname>Wang</surname> <given-names>Z.</given-names></name> <name><surname>Cooper</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>CpG ODN-induced matrix metalloproteinase-13 expression is mediated via activation of the ERK and NF-&#x003BA;B signalling pathways in odontoblast cells</article-title>. <source>Int. Endod. J.</source> <volume>46</volume>, <fpage>666</fpage>&#x02013;<lpage>674</lpage>. <pub-id pub-id-type="doi">10.1111/iej.12043</pub-id><pub-id pub-id-type="pmid">23331101</pub-id></citation>
</ref>
</ref-list>
</back>
</article>